104¦~4¤ë¸¹ ¹D ªk ªk °T (276)

DEEP & FAR

 

 

¬ü°ê³Ì°ªªk°|½s¸¹10-1150 
Mayo Collaborative Service, DBA Mayo
 Medical Laboratories, et al. v. 
Prometheus Laboratories Inc.

 

§d©É¬À ¸ê²`±M§Q¤uµ{®v

¡P ¥xÆW¤j¾Ç¶éÃÀ¾Ç¨t

¡P ¥xÆW¤j¾Ç´Óª«¬ì¾Ç¬ã¨s©Ò

 

 

¦]¬°©Ò½Ð¨Dªº¤èªk¯A¤ÎÂǥѧ뤩²¸áIËïÃĪ«¨ÓÂà´«¤HÅé¥H¤ÎÂǥѤÀªR¦å²G¨ÓÂà´«¦å²G¨Ó¨M©w¥NÁª«ªº¶q¡A¦Ó±À½×©Ò½Ð¨Dªº¤èªk¦]¦¹¬O±M§Q¾A®æªº¡C628 F. 3d, at 1356-1357¡C

µM¦Ó¡A³o¨ÇÂà´«¤¤ªº²Ä¤@­ÓÂà´«¬OµLÃöªº¡C¦p§Ú­Ì¥ý«e©Ò«ü¥Xªº¡A¸Ó¡§§ëÃÄ¡¨¨BÆJ¶ÈÀ°¦£¬D¥X¥i¯à¹ïÀ³¥Î¦ÛµMªk«h·P¿³½ìªº¤@¸s¤H¡C°Ñ¦Òsupra, at 9¡C¥H¤Î¡A°²¦p¬ì¾Çµo®i¤@­Ó¤£²o¯A¦¹Âà´«ªº¥þµM¤£¦Pªº¨t²Î¡A¥H¥Î©ó¨M©w¥NÁª«¶q¡A²Ä¤G¨BÆJ¥i¦b¤£Âà´«¦å²Gªº±¡ªp¤U³Qº¡¨¬¡C°Ñ¦Òsupra, at 18¡CµL½×¦p¦ó¡AÁnºÙ¡§¾÷±ñ©ÎÂà´«´ú¸Õªk¡¨¹ï©ó¥i±M§Q©Ê¬O¡§­«­n¥B¦³¥Îªº½u¯Á¡¨ªº¦P®É¡A§Ú­Ì±q¥¼«ÅºÙ¥ç¥¼·t¥Ü¸Ó´ú¸Õªk³Ó¹L¡§¦ÛµMªk«h¡¨ªº±Æ°£¡CBilski, supra, at __ (slip op., at 6-7)(¥[¤J­«ÂI)¡C¬JµM¦p¦¹¡A¦b³o¸Ì¸Ó´ú¸Õªk¤£¥i¦æ¡C

¨ä¦¸¡APrometheusª§½×¡A¦]¬°¨ä±M§Q½Ð¨D¶µ©ÒÅé²{ªº¯S©w¦ÛµMªk«h¬O¯U¹i¥B¯S©wªº¡A¸Ó±M§QÀ³³Q¤ä«ù¡C¦]¦¹¡A¨ä¹ªÀy§Ú­Ì°ò©ó¥L­Ì¦b²{¦b©Î¬O¥¼¨Ó¬O§_·|ÅãµÛ§«Ãª¨ä¥L»â°ì¤¤ªº³Ð·s¡A¦Ó´y­z¦ÛµMªk«h¤§¶¡ªº®t²§¡C¨£µªÅG²z¥Ñ®Ñ42-46­¶¡F¥ç°Ñ¦ÒLemley 1342-1344 (°µ¥X¬Û¦üªºª§½×)¡C

¦ý¬O¡A¦¹³B°ò¥»¥\¯àªº¦Ò¼{¬O¤@­Ó¬Û¹ïªº¦Ò¼{¡G¬Û¹ï©óµo©ú¤Hªº°^Äm¡A¦h¤Ö¥¼¨Óªº³Ð·s³Qªýê¡C°Ñ¦Òsupra, at 17¡C°ò©ó¤@­Ó¯U¹i¦ÛµMªk«hªº±M§Q¥i¯à¤£·|¹³°ò©ó·R¦]´µ©Z¬Û¹ï½×ªº±M§Q¤@¼ËÄY­«¦aªýꥼ¨Óªº¬ã¨s¡A¦ý¬O¸Óµo²{ªº³Ð·s»ù­È¤]«Ü¤p¡C

 

¡]«ÝÄò¡^